Stereotactic Robotic Body Radiotherapy for Patients With Unresectable Hepatic Oligorecurrence

Favorable survival and toxicity results support the potential paradigm shift in which the use of SBRT in oligorecurrent liver disease could benefit patients with unresectable or resectable liver metastases.